AI Science Tracker
EN

Machine learning-based survival modeling reveals distinct surgical benefits across molecular subtypes in young women with de novo metastatic breast cancer

Affiliation not stated in the reviewed material · 30 Sep 2026 · chemistry

Discovery

Machine learning-based survival modeling reveals distinct surgical benefits across molecular subtypes in young women with de novo metastatic breast cancer

Source check: Source checked. Not independent scientific confirmation.

Finding: Machine-learning survival analyses in young women with de novo metastatic breast cancer identified molecular-subtype differences in observed surgical-benefit associations; this is retrospective treatment-effect modeling, not causal proof.

Technology: Machine-learning survival models stratified by breast-cancer molecular subtype

Publication: Preprint · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.

AI contribution
Uses survival modeling stratified by molecular subtype to compare observed surgical-benefit associations in young women with de novo metastatic breast cancer.
Test and result
The retrospective survival analysis compares observed surgical-benefit associations across molecular subtypes in young women with de novo metastatic breast cancer; it does not establish causal benefit.
Limitation / still unknown
The subtype-specific treatment associations are retrospective and do not establish a causal benefit from surgery.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://doi.org/10.21203/rs.3.rs-10816106/v1 · https://europepmc.org/article/PPR/PPR1331157 · https://www.researchsquare.com/article/rs-10816106/v1.pdf

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.

Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 3/5 · Validation 2/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open in the full catalog for filters, charts and related discoveries. Browse chemistry discoveries.

Related catalog entries

Links use documented relationships where available, plus shared catalog context. A shared topic or model family does not establish a scientific dependency.